The demand for Rapid Detection methods in the Cell and Gene Therapy space has evolved from an amenity to a necessity. This presentation will explore two common tests required for Cell and Gene Therapy Products: Sterility and Mycoplasma testing. Beyond that, this presentation will explore the requirements and capabilities of two Rapid Methods specifically: Rapid Sterility by Respiration Detection and Rapid Mycoplasma testing by quantitative PCR.

In this webinar, viewers will gain insight into Rapid Sterility testing methods, with a focus on Rapid Detection Via Respiration. Additionally, Rapid Mycoplasma testing will be discussed, with details on qPCR as the method of choice. In both tests, requirements, strengths, and challenges to each method will be explored.

Who should attend:

• Quality Assurance/Control Specialists
• Regulatory Affairs Professionals
• Researchers and Scientists
• Microbiology Lab Analysts